Testing version — LOERadar is in active testing. Features and data may change.
Generic Opportunities
No patents, no generics — first-mover opportunities.
What are uncontested opportunities? These are NDA drugs listed as Reference Listed Drugs (RLDs) in the FDA Orange Book that have no listed patents and no approved generic equivalents.